Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Treatment challenges in and outside a network setting: Head and neck cancers.

Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):40-45. doi: 10.1016/j.ejso.2018.02.007. Epub 2018 Feb 14. Review.

PMID:
29478741
2.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

3.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

4.

Epidemiology of rare cancers and inequalities in oncologic outcomes.

Gatta G, Trama A, Capocaccia R; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):3-11. doi: 10.1016/j.ejso.2017.08.018. Epub 2017 Sep 19.

PMID:
29032924
5.

Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?

Bergamini C, Locati L, Bossi P, Granata R, Alfieri S, Resteghini C, Imbimbo M, Fallai C, Orlandi E, Tana S, Iacovelli NA, Guzzo M, Ibba T, Colombo S, Bianchi R, Pizzi N, Fontanella W, Licitra L.

Oral Oncol. 2016 Mar;54:54-7. doi: 10.1016/j.oraloncology.2016.01.001. Epub 2016 Jan 13.

PMID:
26774920
6.

Networking in rare cancers: What was done, what's next.

Frezza AM, Trama A, Blay JY, Casali PG.

Eur J Surg Oncol. 2019 Jan;45(1):16-18. doi: 10.1016/j.ejso.2018.03.030. Epub 2018 Apr 12.

PMID:
29685758
7.

Medical Error Prevention.

Rodziewicz TL, Hipskind JE.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 27.

8.

The Case Volume Issue in Head and Neck Oncology.

Alfieri S, Orlandi E, Bossi P.

Curr Treat Options Oncol. 2017 Oct 27;18(11):65. doi: 10.1007/s11864-017-0507-8. Review.

PMID:
29079897
9.

Survey of Michigan dentists and radiation oncologists on oral care of patients undergoing head and neck radiation therapy.

Patel Y, Bahlhorn H, Zafar S, Zwetchkenbaum S, Eisbruch A, Murdoch-Kinch CA.

J Mich Dent Assoc. 2012 Jul;94(7):34-45.

PMID:
22970504
10.

The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer.

Bossi P, Alfieri S.

Curr Treat Options Oncol. 2016 Oct;17(10):53. doi: 10.1007/s11864-016-0431-3. Review.

PMID:
27520784
11.

The economic burden of head and neck cancer: a systematic literature review.

Wissinger E, Griebsch I, Lungershausen J, Foster T, Pashos CL.

Pharmacoeconomics. 2014 Sep;32(9):865-82. doi: 10.1007/s40273-014-0169-3. Review.

12.

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2017.09.025. Epub 2017 Nov 3. Review.

PMID:
29108961
13.

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.

Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):46-51. doi: 10.1016/j.ejso.2017.08.019. Epub 2017 Oct 16. Review.

PMID:
29126671
14.

Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours.

Laskaratos FM, Caplin M.

Eur J Surg Oncol. 2019 Jan;45(1):52-59. doi: 10.1016/j.ejso.2018.03.012. Epub 2018 Mar 22. Review.

PMID:
29685756
15.

Current evidence on the burden of head and neck cancers in Nigeria.

da Lilly-Tariah OB, Somefun AO, Adeyemo WL.

Head Neck Oncol. 2009 May 28;1:14. doi: 10.1186/1758-3284-1-14. Review.

16.

Treatment challenges in and outside a network setting: Soft tissue sarcomas.

Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group.

Eur J Surg Oncol. 2019 Jan;45(1):31-39. doi: 10.1016/j.ejso.2017.09.015. Epub 2017 Sep 19.

PMID:
28985973
17.

Perspective of physicians within a multidisciplinary team: content validation of the comprehensive ICF core set for head and neck cancer.

Leib A, Cieza A, Tschiesner U.

Head Neck. 2012 Jul;34(7):956-66. doi: 10.1002/hed.21844. Epub 2011 Sep 22.

PMID:
21953733
18.

Institutional clinical trial accrual volume and survival of patients with head and neck cancer.

Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, Silverman CL, Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison ML.

J Clin Oncol. 2015 Jan 10;33(2):156-64. doi: 10.1200/JCO.2014.56.5218. Epub 2014 Dec 8.

19.

A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?

Licitra L, Bossi P, Locati LD.

Curr Opin Oncol. 2006 May;18(3):253-7. Review.

PMID:
16552237
20.

Improving treatment results with reference centres for rare cancers: where do we stand?

Ray-Coquard I, Pujade Lauraine E, Le Cesne A, Pautier P, Vacher Lavenue MC, Trama A, Casali P, Coindre JM, Blay JY.

Eur J Cancer. 2017 May;77:90-98. doi: 10.1016/j.ejca.2017.02.006. Epub 2017 Apr 3. Review.

PMID:
28384534

Supplemental Content

Support Center